Core Viewpoint The Cannabist Company is undergoing significant restructuring through strategic asset sales and has initiated proceedings under the Companies' Creditors Arrangement Act (CCAA) in Canada to facilitate these transactions and manage its financial challenges. Strategic Transactions - The Cannabist Company has entered into definitive agreements to sell its cannabis operations in Ohio and Delaware, with Holistic Industries acquiring Ohio assets for $47 million and Parma Holdco acquiring Delaware assets for $16.5 million [5][6]. - A non-binding memorandum of understanding has been established for the potential sale of operations in Illinois, New Jersey, Colorado, Massachusetts, Maryland, and West Virginia [7]. CCAA Proceedings - The company has commenced voluntary CCAA proceedings to support the completion of the strategic transactions and preserve liquidity while winding down operations in non-strategic markets like New York and Pennsylvania [2][9]. - An Initial Order has been obtained from the Ontario Superior Court, providing a stay of proceedings for an initial period of ten days and appointing FTI Consulting Canada Inc. as the Monitor [8]. Financial Restructuring - The company has entered into a support agreement with senior secured noteholders, who collectively hold over 60% of the outstanding principal amount of the company's senior secured notes [2]. - The company has appointed SierraConstellation Partners LLC as Chief Restructuring Officer, pending court approval [10]. Operational Changes - The Cannabist Company has ceased operations in New York and is in the process of ceasing operations in Pennsylvania as part of its restructuring efforts [9].

Core Insights - SNDL reported its first year of positive full-year adjusted operating income, attributed to operational efficiencies and synergies from the Indiva acquisition [1] - The company emphasized free cash flow as a key measure of financial health, more than doubling it to CAD 18 million in 2025 [2] - SNDL achieved record full-year net revenue, gross profit, adjusted operating income, and free cash flow, despite a late-year slowdown in Canadian cannabis retail demand [3][4] Financial Performance - Full-year net revenue rose to CAD 946 million, up 2.8% year-over-year, driven by 11% growth in cannabis segments, offset by a 3% decline in liquor [6][8] - Gross profit reached CAD 70.2 million, a new quarterly record, with a gross margin of 27.8%, reflecting a 110-basis-point improvement [8][9] - Adjusted operating income for the fourth quarter was CAD 12.8 million, marking a record quarterly result [8] Segment Analysis - Cannabis retail generated a record revenue of CAD 330 million for the full year, up 6%, supported by same-store sales growth and new store openings [12] - Liquor retail experienced a revenue decline of approximately 3%, but gross margin improved, reaching 26.0% in Q4 [10][11] - The company noted a late-2025 slowdown in cannabis retail due to market saturation and reduced traffic [13] Strategic Initiatives - SNDL ended 2025 with no debt and over CAD 250 million in unrestricted cash, positioning itself for disciplined capital deployment [5][15] - The company is pursuing M&A opportunities and international expansion, with a focus on EU GMP certification [19][20] - SNDL has simplified its U.S. investment portfolio, with ongoing liquidation processes for certain positions [21] Operational Improvements - Management highlighted operational simplification efforts, including the consolidation of ERP systems to optimize processes [17] - Capital expenditures increased by nearly 50% in 2025, primarily for new store openings [16] - The company repurchased 15.1 million shares since Q4 2024, indicating a commitment to shareholder returns [18]

Core Insights - Cronos Group Inc. reported fiscal Q4 2025 earnings with quarterly revenue of $44.53 million, representing a 47.1% year-over-year increase and exceeding expectations by $5.78 million [1] - The revenue growth was attributed to strong demand for leading brands, completion of Cronos GrowCo expansion, and increased contributions from international markets [2] - Gross profit for the quarter was $16.2 million, an increase of $5.4 million year-over-year, driven by a higher average selling price due to a favorable sales mix from Israel and other international markets [2] Future Outlook - The company is optimistic about its acquisition of CanAdelaar, which will facilitate its entry into the European market [3] - Cronos Group Inc. is a cannabinoid company that cultivates, produces, and markets cannabis products globally, offering a variety of products under brands such as Spinach, Lord Jones, and PEACE NATURALS [3]

Core Insights - Cronos Group Inc. (NASDAQ:CRON) is recognized as one of the best pot stocks to buy according to hedge funds, with 19 hedge funds holding stakes in the company as of Q3 2025 [4] Group 1: Analyst Ratings and Price Targets - TD Securities initiated coverage of Cronos Group with a Buy rating and a price target of C$4.50, highlighting its portfolio of iconic Canadian cannabis brands and scalable cost structure [2] - Canaccord analyst Kenric Tyghe also initiated coverage with a Buy rating and a price target of C$4.25, emphasizing the importance of the acquisition of CanAdelaar and the expansion of Cronos Growing Company for enhancing vertical integration and international reach [3] Group 2: Company Overview - Founded in 2012 and headquartered in Toronto, Cronos Group Inc. is a cannabinoid company that cultivates, produces, and markets cannabis products globally, offering a range of products including dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under brands like Spinach, Lord Jones, and PEACE NATURALS [4]

Industry Overview - The U.S. cannabis industry is evolving as it approaches 2026, with growth being uneven but still presenting opportunities [1] - Operators are focusing on efficiency and profitability, while investors are monitoring federal reform progress [1][2] - Rescheduling discussions have improved overall sentiment, but capital access remains limited for many companies [1] Market Dynamics - Leading multi-state operators are building scale, with strong retail footprints providing steady revenue streams [2] - Brand development is crucial for defending margins as competition tightens, making operational discipline critical [2] - Stability is a priority for investors, with balance sheet strength and positive adjusted EBITDA trends being more important than rapid expansion [3] Key Markets - Florida, Illinois, Pennsylvania, and Ohio are identified as key battleground states with strong consumer demand [3] - Pricing pressure continues in mature regions, making scale and branding competitive advantages [3] Notable Companies - Ascend Wellness Holdings is refining operations and focusing on efficiency, with annual revenue in the half-billion-dollar range and positive adjusted EBITDA trends [4][9][10] - Cansortium, operating under the FLUENT brand, is focused on Florida and maintains a vertically integrated structure, with recent strategic moves improving its balance sheet [11][14][15] - Cresco Labs is one of the largest U.S. multi-state operators, with a broad footprint and strong brand presence, generating annual revenue exceeding several hundred million dollars [16][18][20] Financial Performance - Ascend has reported fluctuating quarterly revenue due to pricing pressure but has shown improvement in adjusted EBITDA margins [9] - Cansortium's revenue reflects industry volatility, but cost reductions have supported adjusted EBITDA stability [14] - Cresco has consistently maintained positive adjusted EBITDA, with liquidity improving following balance sheet adjustments [19]

Core Viewpoint - The Cannabist Company has extended its forbearance agreement with senior noteholders, allowing them to defer exercising their rights until February 27, 2026, amidst ongoing financial negotiations [1][2]. Group 1: Forbearance Agreement - The Cannabist Company announced a further extension of the forbearance agreement with an ad hoc group of noteholders holding the Company's 9.25% Senior Secured Notes and 9.00% Senior Secured Convertible Notes, both due December 31, 2028 [1]. - The forbearance agreement allows noteholders to refrain from exercising their rights and remedies under the governing indenture and applicable law until February 27, 2026 [1]. Group 2: Company Overview - The Cannabist Company, formerly known as Columbia Care, is a prominent player in the cannabis industry, operating 69 facilities across 11 U.S. jurisdictions, including 54 dispensaries and 15 cultivation and manufacturing facilities [1]. - The company launched its retail brand, Cannabist, in 2021, establishing a national dispensary network that utilizes proprietary technology platforms [1]. - The Cannabist Company offers a diverse range of cannabis products, including flower, edibles, oils, and tablets, and manufactures several popular brands [1].

Core Insights - Gotham has launched the Gotham Growth Project (GGP), a business accelerator aimed at supporting cannabis consumer brands from underserved communities, with an initial focus on Black-owned businesses in New York City [1][4] Group 1: Program Overview - GGP provides hands-on business strategy and mentorship to help founders build sustainable cannabis businesses [1] - The program includes six focused sessions covering various aspects of business development [2][6] - The program will conclude with a live pitch showcase at Gotham's semiannual leadership conference in October [3] Group 2: Program Objectives and Structure - The mission of GGP is to assist founders in transitioning from traction to scalability, addressing the challenges faced by diverse entrepreneurs [2] - Founders will engage in a curriculum that combines expert instruction, peer collaboration, and practical assignments to tackle real-world business challenges [3] Group 3: Eligibility and Application - Eligible applicants must be at least 51% Black-owned, have been in business for at least one year, and have at least one product on the market [5] - Applications are currently open and will close on March 11 at 5:00 p.m. ET [5]

Industry Overview - The U.S. cannabis sector is at a critical inflection point as of February 2026, with improved market sentiment but selective investor interest [1] - Long-term demand for cannabis continues to grow despite price volatility, with state-level legalization expanding and medical programs remaining stable [2] - Profitability is now prioritized over rapid expansion, leading companies to tighten operations and protect margins [3] Company Highlights Trulieve Cannabis Corp. (TCNNF) - Trulieve is a dominant cannabis operator in the U.S., operating a vertically integrated business model across cultivation, processing, distribution, and retail sales [4] - The company has a significant presence in Florida, which serves as its core revenue engine, while also expanding into states like Pennsylvania, Arizona, Maryland, Ohio, and Connecticut [5] - As of early 2026, Trulieve operates over 230 dispensaries nationwide, enhancing brand visibility and customer loyalty [7] - The company focuses on disciplined expansion, targeting profitable markets to remain competitive during industry slowdowns [9] - Financially, Trulieve emphasizes cash flow and balance sheet strength, with stable revenue and healthy gross margins despite pricing pressure [10] - Management has taken steps to address near-term debt obligations, improving liquidity and reducing financial risk [11] - Trulieve continues generating meaningful EBITDA and maintains sufficient cash reserves for selective growth [12] - The company is well-positioned for future growth as regulatory clarity improves [13] Curaleaf Holdings, Inc. (CURLF) - Curaleaf is the largest cannabis company in the U.S. by revenue, operating across numerous states and markets, providing diversification and risk mitigation [13] - The company operates over 160 dispensaries, with a significant retail presence in Florida and strong positions in New Jersey, New York, Arizona, and Illinois [14] - Curaleaf focuses on operational efficiency, optimizing existing assets rather than aggressive expansion, which helps preserve margins [17] - Financially, Curaleaf generates over a billion dollars in annual revenue, with recent trends showing stabilization and improved gross margins [18] - The company is focused on reducing expenses and streamlining operations, with debt management being a priority [19] - While net profitability remains elusive, losses have narrowed, reflecting disciplined spending and operational focus [20] Verano Holdings Corp. (VRNOF) - Verano is a vertically integrated cannabis operator with a footprint in key markets such as Illinois, Florida, New Jersey, Pennsylvania, and Arizona [21] - The company operates retail dispensaries under brands like Zen Leaf and MÜV, maintaining a strategically placed retail network [22] - Verano emphasizes product quality and consistent branding to attract loyal customers, balancing retail growth with operational discipline [24] - Financially, Verano has faced revenue pressure but has focused on cost control to protect margins [25] - The company has significant net losses due to ongoing investments and restructuring costs, but prioritizes operational efficiency [26] - Verano is considered a higher-risk, higher-reward operator, with potential upside if market conditions improve [26]

Core Viewpoint - The Cannabist Company has entered into a forbearance agreement with noteholders due to liquidity challenges, following its decision to forgo interest payments on its senior secured notes [1][2][4]. Group 1: Forbearance Agreement - The Cannabist Company has signed a forbearance agreement with an ad hoc group of noteholders holding over 75% of its 9.25% and 9.00% Senior Secured Notes due December 31, 2028 [1][4]. - The forbearance agreement allows the noteholders to refrain from exercising their rights until February 17, 2026, due to the company's failure to make interest payments [4]. Group 2: Financial Strategy - On December 31, 2025, the company opted not to make interest payments to enhance short-term financial flexibility and preserve liquidity while evaluating strategic alternatives, including asset sales [2][3]. - The non-payment of interest during the 30-day grace period constitutes an event of default, prompting discussions with noteholders about potential strategies to address liquidity needs [2][3]. Group 3: Company Overview - The Cannabist Company, formerly known as Columbia Care, is a leading cultivator and retailer of cannabis products in the U.S., operating 77 facilities across 12 jurisdictions [5]. - The company offers a wide range of cannabis products and has established a national dispensary network under its retail brand, Cannabist [5].

Core Viewpoint - Ascend Wellness Holdings, Inc. has opened a new dispensary in Englewood, Ohio, expanding its retail presence in the state's regulated cannabis market, catering to both medical and non-medical customers [1][2]. Group 1: Company Expansion - The new dispensary in Englewood is part of Ascend's strategy to enhance its retail footprint in Ohio, where it already operates multiple locations [2]. - Ascend aims to provide safe access and quality products while focusing on a patient- and customer-centric retail experience [2]. Group 2: Grand Opening and Community Engagement - A grand opening event is scheduled for January 16, inviting local patients, customers, and community members to explore the new facility and learn about Ascend's product offerings [3]. - The dispensary is designed to create an efficient and welcoming shopping experience, featuring a variety of cannabis products from leading brands [4]. Group 3: Product Offering and Customer Engagement - The Englewood dispensary will offer a wide range of cannabis products, including flower, vapes, edibles, and concentrates, with options for in-store or online purchases [4]. - Ascend has introduced a revamped loyalty program, the Ascenders Club, to reward customers for their purchases and in-store deals [5]. Group 4: Operational Details - The Englewood dispensary will operate daily from 8:00 a.m. to 11:00 p.m., serving both medical and non-medical customers [6]. - For further information about Ascend and its dispensaries, customers can visit the company's website [6]. Group 5: Company Overview - Ascend Wellness Holdings, Inc. is a vertically integrated cannabis operator with assets across several states, including Ohio, and produces a curated selection of cannabis products for retail and wholesale [7].